|£44,263 to £56,021 per annum
|11th December 2023
|1st January 2024
Location: Southampton General Hospital
Faculty of Medicine
Wessex Investigational Sciences Hub (WISH) Laboratory
The Southampton Experimental Cancer Medicines Centre (ECMC) is looking for a high-quality translational scientist to lead delivery of our exciting portfolio of clinical trial endpoints in early phase studies of novel cancer therapies.
Cancer Research UK and the National Institutes of Health Research core funds the Southampton Experimental Cancer Medicines Centre (ECMC) to provide infrastructure for the delivery of early phase cancer trials. Key to the success of these trials is the delivery of high-quality translational endpoints so that we may learn as much as possible from each patient participating in studies. The Southampton ECMC has a broad and expanding portfolio of novel agent studies across a range of cancers. In collaboration with the Southampton Clinical Trials Unit and the new Southampton Centre for Cancer Immunology we are building upon this base and are looking for an individual to lead operational delivery of our ambitious programme.
The post will be based in the Wessex Investigational Sciences Hub (WISH) laboratory specifically designed to host regulated clinical trial work within all fields of experimental cancer medicines (including cancer immunotherapy), Nutrition, Respiratory disease, and Stratified/personalised medicine, and situated within the Southampton General Hospital site. This job role falls within the remit of the Cancer Sciences Unit in the Faculty of Medicine which provides a stimulating working environment for more than 140 scientists, clinicians and associated staff, investigating cancer and its treatment.
The post holder will support a portfolio of early phase trials working to oversee the delivery of a range of translational clinical trial endpoints. They will work closely with a number of Trial Development Groups and Trial Management Groups to design novel translational endpoints, project manage their validation and delivery and participate, as collaborators, in funding applications. There is very close working with the Southampton Clinical Trials Unit. The post holder will share line management responsibilities for post doctorate and technical stall in the ECMC and also work closely with the Cancer Research UK Centre for Drug Development Biomaker Team who deliver first in human clinical trials.
The Southampton ECMC is part of a national network. The post holder will be expected to engage with other ECMC sites and participate in network wide activities in order to forward the strategic aims of both our local ECMC and the network as a whole (http://www.ecmcnetwork.org.uk/).
They will be expected to undertake national leadership roles within the ECMC Network.
You should have significant relevant research experience and be qualified to PhD level (or equivalent) in a biological sciences. It is desirable to have previous research experience in the field of cancer therapeutics/Cancer Immunotherapy.
We are looking for someone who is motivated, a good team player with excellent communication skills, capable of delivering research tasks timely and with accuracy. You will be part of a multi-disciplinary team that includes post-docs, PhD students, clinicians, and also junior staff that you may help supervise. Experience of working with clinical samples and a good laboratory practice framework is essential.
This is a full-time, fixed-term appointment until March 2028.
For an informal discussion or to arrange a visit, please email Dr Andrew Davies (firstname.lastname@example.org)
Type / Role: